{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:27:12Z","timestamp":1793406432709,"version":"4.5.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sociedad Argentina de Infectolog\u00eda"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bloodstream infections (BSI) caused by metallo-beta-lactamase (MBL)-producing Enterobacterales (E) are associated with high mortality. However, in most Latin American countries there is a lack of clinical and microbiological data on BSI caused by MBL-E.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This preplanned subgroup analysis of the multicenter, observational, prospective EMBARCAR study focused on adult patients with BSI caused by MBL-E in Argentina. Logistic regression adjusted by propensity scores (PS) for the treatment with ceftazidime-avibactam plus aztreonam (CAZ\/AVI plus ATM) were used to identify variables associated with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 140 patients with BSI caused by MBL-producing Enterobacterales were included. Median age was 59 years (IQR 46\u201370), and most patients were male (61%). Most frequent comorbidities were diabetes 23%, class III obesity 19%, and chronic renal failure 19%. Two thirds of patients were hospitalized in critical care units, 60% required mechanical ventilation and 38% presented with shock. Most frequent isolated microorganisms were Klebsiella pneumoniae (75%) and Serratia marcescens (12%). Most patients (64%) received combination therapy and 23% received CAZ\/AVI plus ATM. Thirty-day mortality was 41%. In the multivariate PS adjusted analysis, INCREMENT-CPE score \u22658 was associated with increased risk of mortality (odds ratio [OR] 3.63; 95% CI: 1.13, 11.7), while CAZ\/AVI plus ATM therapy with a lower risk of death (OR 0.18; 95% CI: .05, .58).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary, BSI due to MBL-producing Enterobacterales resulted in a high mortality rate in our country. The use of CAZ\/AVI plus ATM was associated with a decreased mortality. Better access to these antibiotics should be granted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag124","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:49:55Z","timestamp":1772542195000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-\u03b2-Lactamase\u2013Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-5208","authenticated-orcid":false,"given":"Ezequiel","family":"Cordova","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit (EC, MIL) and Department of Medicine (CS), Hospital Cosme Argerich , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-2813","authenticated-orcid":false,"given":"Juan Pablo","family":"Balbuena","sequence":"additional","affiliation":[{"name":"Department of Research and Infectious Diseases Service, Instituto M\u00e9dico Platense , La Plata ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia","family":"Mykietiuk","sequence":"additional","affiliation":[{"name":"Department of Research and Infectious Diseases Service, Instituto M\u00e9dico Platense , La Plata ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9521-0849","authenticated-orcid":false,"given":"Javier","family":"Farina","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital de Alta Complejidad Cuenca Alta Nestor Kirchner , Ca\u00f1uelas ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-9322","authenticated-orcid":false,"given":"Marcelo","family":"Ga\u00f1ete","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, HIGA Evita Lan\u00fas , Lan\u00fas ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-6318","authenticated-orcid":false,"given":"Pablo","family":"Scapellato","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital Santojanni , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda In\u00e9s","family":"Lespada","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit (EC, MIL) and Department of Medicine (CS), Hospital Cosme Argerich , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8472-7965","authenticated-orcid":false,"given":"Esteban","family":"Nannini","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Sanatorio Brit\u00e1nico , Rosario ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5135-6047","authenticated-orcid":false,"given":"Rosa","family":"Contreras","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital Marcial Quiroga , San Juan ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-1299","authenticated-orcid":false,"given":"Eleonora","family":"Cunto","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Hospital F J Mu\u00f1iz , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-6386","authenticated-orcid":false,"given":"Laura","family":"Barcelona","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital Bernardo Houssay , Vicente L\u00f3pez ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5840-5869","authenticated-orcid":false,"given":"Fernando","family":"Pasteran","sequence":"additional","affiliation":[{"name":"Antimicrobials Service, National Reference Laboratory for Antimicrobials, Department of Bacteriology, Instituto Nacional de Enfermedades Infecciosas, ANLIS \u201cCarlos G. Malbr\u00e1n\u201d , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4158-6255","authenticated-orcid":false,"given":"Claudia","family":"Salgueira","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service and Infection Control, Sanatorio Anchorena Recoleta , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-5420","authenticated-orcid":false,"given":"Mart\u00edn","family":"Hojman","sequence":"additional","affiliation":[{"name":"Infectious Diseses Unit, Hospital Gral. De Agudos \u201cBernardino Rivadavia\u201d , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1999-1310","authenticated-orcid":false,"given":"Miriam","family":"Blanco","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Hospital El Cruce , Florencio Varela ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3553-802X","authenticated-orcid":false,"given":"Horacio","family":"Lopez Alegre","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, HIGA Presidente Per\u00f3n , Avellaneda ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-7818","authenticated-orcid":false,"given":"William E","family":"Cox Fernandez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Sanatorio Privado San Jos\u00e9 , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7720-4098","authenticated-orcid":false,"given":"Cecilia","family":"Ezcurra","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital Alem\u00e1n , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar\u00edo","family":"Godoy","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Hospital El Cruce , Florencio Varela ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A","family":"Biglia","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital Quemados \u201cDr. Arturo Illia\u201d , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Lopez Furst","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Sanatorio Julio M\u00e9ndez , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0514-7004","authenticated-orcid":false,"given":"Gustavo","family":"Mendez","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Hospital Escuela de Agudos Dr. Ram\u00f3n Madariaga , Posadas ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda F","family":"Aguirre Rios","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Hospital C\u00e9sar Milstein , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Altclas","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service and Infection Control, Sanatorio Trinidad Mitre , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0628-8064","authenticated-orcid":false,"given":"C\u00e9sar","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit (EC, MIL) and Department of Medicine (CS), Hospital Cosme Argerich , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-6564","authenticated-orcid":false,"given":"Martin E","family":"Stryjewski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Cl\u00ednicas \u201cNorberto Quirno\u201d (CEMIC) , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2026041703023057600_ofag124-B1","doi-asserted-by":"crossref","first-page":"107449","DOI":"10.1016\/j.ijantimicag.2025.107449","article-title":"Epidemiology and outcomes associated with MBL-producing Enterobacterales: a systematic literature review","volume":"65","author":"Kanj","year":"2025","journal-title":"Int J Antimicrob Agents"},{"key":"2026041703023057600_ofag124-B2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciad725","article-title":"Clinical features and outcomes of infections caused by metallo-\u03b2-lactamase\u2013producing Enterobacterales: a 3-year prospective study from an endemic area","volume":"78","author":"Falcone","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026041703023057600_ofag124-B3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2026041703023057600_ofag124-B4","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"IDSA 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026041703023057600_ofag124-B5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/ciaf259","article-title":"Carbapenem-resistant gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort study","volume":"81","author":"Balbuena","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026041703023057600_ofag124-B6","author":"Clinical and Laboratory Standards Institute"},{"key":"2026041703023057600_ofag124-B7"},{"key":"2026041703023057600_ofag124-B8","author":"National Reference Laboratory for Antimicrobial Resistance ANLIS\/Malbran Argentina"},{"key":"2026041703023057600_ofag124-B9","author":"National Reference Laboratory for Antimicrobial Resistance ANLIS\/Malbran Argentina"},{"key":"2026041703023057600_ofag124-B10","first-page":"101175","article-title":"Mortality of metallo-\u03b2-lactamase-producing Enterobacterales bacteremias with combined ceftazidime-avibactam plus aztreonam vs. Other active antibiotics: a multicenter target trial emulation","volume":"49","author":"Huespe","year":"2025","journal-title":"Lancet Reg Health Am"},{"key":"2026041703023057600_ofag124-B11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2026041703023057600_ofag124-B12","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/CMR.00115-18","article-title":"NDM Metallo-\u03b2-lactamases and their bacterial producers in health care settings","volume":"32","author":"Wu","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2026041703023057600_ofag124-B13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/antibiotics13121139","article-title":"National multicenter study on the prevalence of carbapenemase-producing Enterobacteriaceae in the post-COVID-19 era in Argentina: the RECAPT-AR study","volume":"13","author":"Echegorry","year":"2024","journal-title":"Antibiotics"},{"key":"2026041703023057600_ofag124-B14","doi-asserted-by":"crossref","first-page":"e00397","DOI":"10.1128\/AAC.00397-20","article-title":"Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline","volume":"64","author":"Boyd","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2026041703023057600_ofag124-B15","doi-asserted-by":"crossref","first-page":"107113","DOI":"10.1016\/j.ijantimicag.2024.107113","article-title":"Activity of aztreonam-avibactam against Enterobacterales resistant to recently approved beta-lactamase inhibitor combinations collected in Europe, Latin America, and the Asia-Pacific Region (2020-2022)","volume":"63","author":"Sader","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"2026041703023057600_ofag124-B16","doi-asserted-by":"crossref","first-page":"e02243","DOI":"10.1128\/AAC.02243-16","article-title":"Can Ceftazidime-Avibactam and aztreonam overcome \u03b2-lactam resistance conferred by Metallo-\u03b2-Lactamases in Enterobacteriaceae?","volume":"61","author":"Marshall","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026041703023057600_ofag124-B17","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of Ceftazidime-avibactam plus Aztreonam in patients with bloodstream infections caused by Metallo-\u03b2-lactamase-producing enterobacterales","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026041703023057600_ofag124-B18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2026041703023057600_ofag124-B19","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2666-5247(23)00256-2","article-title":"Defining access without excess: expanding appropriate use of antibiotics targeting multidrug-resistant organisms","volume":"5","author":"Patel","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026041703023057600_ofag124-B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone","year":"2020","journal-title":"Crit Care"},{"key":"2026041703023057600_ofag124-B21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2026041703023057600_ofag124-B22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1473-3099(24)00499-7","article-title":"Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial","volume":"25","author":"Carmeli","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026041703023057600_ofag124-B23","doi-asserted-by":"crossref","first-page":"dlaf131","DOI":"10.1093\/jacamr\/dlaf131","article-title":"Aztreonam-avibactam for the treatment of serious infections caused by metallo-\u03b2-lactamase-producing gram-negative pathogens: a phase 3 randomized trial (ASSEMBLE)","volume":"7","author":"Daikos","year":"2025","journal-title":"JAC Antimicrob Resist"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag124\/68099397\/ofag124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/4\/ofag124\/68099397\/ofag124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:02:47Z","timestamp":1776409367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag124\/8571757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag124","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,30]]},"article-number":"ofag124"}}